營養基因組學全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計營養基因組學市場將從 2025 年的 6.5 億美元成長到 2034 年的 28.7 億美元，2026 年至 2034 年的複合年成長率為 17.97%。

隨著全球對個人化營養和精準醫療的關注度不斷提高，營養基因組學市場持續擴張。營養基因組學將基因分析與飲食建議結合，旨在最佳化健康、預防疾病並改善代謝功能。消費者對健康、預防醫學和數據驅動型營養的日益關注，正在推動醫療保健、健身和營養補充劑行業對營養基因組學的廣泛應用。

技術創新正在推動市場成長。基因組分析、人工智慧驅動的飲食分析和生物標記整合，使得精準的個人化營養規劃成為可能。數位化平台和穿戴式裝置提供即時追蹤、健康監測和回饋，從而提高依從性和有效性。機能性食品和膳食補充劑正擴大基於個體基因譜進行設計，將科學與個人化健康管理相結合。

未來成長預計將受到公眾意識提升、醫療保健數位化以及監管機構對個人化營養的更廣泛認可的推動。北美和歐洲在先進的醫療保健基礎設施的支持下，引領著這一進程；而亞太地區則在都市化和健康生活方式趨勢的推動下，正經歷著快速成長。生物技術公司、營養補充劑生產商和數位健康平台之間的策略合作正在擴大營養基因組學解決方案的應用。營養基因組學有望透過整合基因組學、營養學和人工智慧驅動的洞察，重新定義個人化健康的概念。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球營養基因體學市場：依應用分類

• 市場分析、洞察與預測
• 肥胖
• 心血管疾病
• 癌症研究
• 其他

第5章：全球營養基因體學市場：依產品分類

• 市場分析、洞察與預測
• 試劑和試劑盒
• 服務

第6章：全球營養基因體學市場：依方法論分類

• 市場分析、洞察與預測
• 唾液
• 口腔內棉花棒
• 血

第7章：全球營養基因體學市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 其他

第8章：全球營養基因體學市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Nutrigenomix
  • The Gene Box
  • Metagenics
  • Xcode Life
  • GX Sciences LLC（Fagron）
  • Cura Integrative Medicine
  • Dnalife
  • Genova Diagnostics（GDX）
  • Holistic Health International LLC

The Nutrigenomics Market size is expected to reach USD 2.87 Billion in 2034 from USD 0.65 Billion (2025) growing at a CAGR of 17.97% during 2026-2034.

The nutrigenomics market is expanding as personalized nutrition and precision health gain global attention. Nutrigenomics integrates genetic profiling with dietary recommendations to optimize health, prevent disease, and enhance metabolic outcomes. Rising consumer interest in wellness, preventive healthcare, and data-driven nutrition is driving adoption across healthcare, fitness, and supplement industries.

Technological innovation is fueling market growth. Genomic sequencing, AI-driven dietary analysis, and biomarker integration enable precise, personalized nutrition plans. Digital platforms and wearable devices allow real-time tracking, health monitoring, and feedback, enhancing compliance and efficacy. Functional foods and supplements are increasingly formulated based on individual genetic profiles, bridging science with personalized wellness.

Future growth is expected from rising awareness, healthcare digitization, and regulatory recognition of personalized nutrition. North America and Europe lead adoption due to advanced healthcare infrastructure, while Asia-Pacific is witnessing rapid growth driven by urbanization and lifestyle health trends. Strategic collaborations between biotech firms, nutraceutical companies, and digital health platforms are expanding accessible nutrigenomics solutions. Nutrigenomics is poised to redefine personalized wellness, combining genomics, nutrition, and AI-driven insights.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Obesity
• Cardiovascular Diseases
• Cancer Research
• Others

By Product

• Reagents & Kits
• Services

By Technique

• Saliva
• Buccal Swab
• Blood

By End Use

• Hospitals & Clinics
• Others

COMPANIES PROFILED

• Nutrigenomix, The Gene Box, Metagenics, Xcode Life, GX Sciences LLC Fagron, Cura Integrative Medicine, dnalife, Genova Diagnostics GDX, Holistic Health International LLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NUTRIGENOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Obesity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cancer Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NUTRIGENOMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NUTRIGENOMICS MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technique
• 6.2. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Buccal Swab Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NUTRIGENOMICS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL NUTRIGENOMICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Application
  • 8.2.2 By Product
  • 8.2.3 By Technique
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Application
  • 8.3.2 By Product
  • 8.3.3 By Technique
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Application
  • 8.4.2 By Product
  • 8.4.3 By Technique
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Application
  • 8.5.2 By Product
  • 8.5.3 By Technique
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Application
  • 8.6.2 By Product
  • 8.6.3 By Technique
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL NUTRIGENOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Nutrigenomix
  • 10.2.2 The Gene Box
  • 10.2.3 Metagenics
  • 10.2.4 Xcode Life
  • 10.2.5 GX Sciences LLC (Fagron)
  • 10.2.6 Cura Integrative Medicine
  • 10.2.7 Dnalife
  • 10.2.8 Genova Diagnostics (GDX)
  • 10.2.9 Holistic Health International LLC